104 Analysis of clinical characteristics, genetic basis, management and arrhythmic outcomes of patients with catecholaminergic polymorphic ventricular tachycardia …

G Tse, S Lee, KB Waleed, JMH Hui, I Lakhani - 2022 - heart.bmj.com
Introduction Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a rare cardiac
ion channelopathy. The aim of this study is to examine the clinical characteristics, genetic …

[HTML][HTML] Clinical characteristics, outcomes, and genetic findings of patients with catecholaminergic polymorphic ventricular tachycardia in Hong Kong: A systematic …

JMH Hui, YHA Lee, K Hui, J Zhou, DI Satti… - Annals of Clinical …, 2022 - journals.lww.com
Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a rare cardiac ion
channelopathy. This was the first systematic review of published works on the clinical …

Arrhythmic outcomes in catecholaminergic polymorphic ventricular tachycardia

S Lee, J Zhou, K Jeevaratnam, I Lakhani, WT Wong… - medRxiv, 2021 - medrxiv.org
Introduction Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a rare cardiac
ion channelopathy. The aim of this study is to examine the genetic basis and identify pre …

Clinical characteristics, genetic findings and arrhythmic outcomes of patients with catecholaminergic polymorphic ventricular tachycardia from China: A systematic …

J Leung, S Lee, J Zhou, K Jeevaratnam, I Lakhani… - Life, 2022 - mdpi.com
Introduction: Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a rare
inherited cardiac ion channelopathy. The present study aims to examine the clinical …

Clinical characteristics, genetic basis and healthcare resource utilisation and costs in patients with catecholaminergic polymorphic ventricular tachycardia: a …

CT Chung, S Lee, J Zhou, OHI Chou… - Reviews in …, 2022 - scholars.cityu.edu.hk
Background: This study examined the clinical characteristics, genetic basis, healthcare
utilisation and costs of catecholaminergic ventricular tachycardia (CPVT) patients from a …

Clinical and genetic profiles of chinese pediatric patients with catecholaminergic polymorphic ventricular tachycardia

Y Yan, L Tang, X Wang, K Zhou, F Hu, H Duan… - Orphanet Journal of …, 2023 - Springer
Backgrounds Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a rare but
lethal cardiac ion channelopathy. Delayed diagnosis and misdiagnosis remain a matter of …

Long-term follow-up of patients with catecholaminergic polymorphic ventricular arrhythmia

M Veith, I El-Battrawy, G Roterberg… - Journal of Clinical …, 2020 - mdpi.com
Background: Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a rare
inherited disorder causing life-threatening arrhythmias. Long-term outcome studies of the …

Nationwide experience of catecholaminergic polymorphic ventricular tachycardia caused by RyR2 mutations

AK Broendberg, JC Nielsen, J Bjerre, LN Pedersen… - Heart, 2017 - heart.bmj.com
Objective The aim of this study was to characterise disease penetrance, course of disease
and use of antiarrhythmic medication and implantable cardioverter-defibrillator (ICD) therapy …

Catecholaminergic Polymorphic Ventricular Tachycardia: Multiple Clinical Presentations of a Genetically Determined Disease

S Jurisic, A Medeiros-Domingo, F Berger… - Journal of Clinical …, 2023 - mdpi.com
Background: Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a rare,
inherited heart rhythm disorder that is caused by variants in genes responsible for cardiac …

Genetic background of catecholaminergic polymorphic ventricular tachycardia in Japan

M Kawamura, S Ohno, N Naiki, I Nagaoka… - Circulation …, 2013 - jstage.jst.go.jp
Background: The genetic background of catecholaminergic polymorphic ventricular
tachycardia (CPVT) has been extensively investigated for the last decade in Western …